Address
Email address
https://euroapteek.eeE-apteek | Euroapteek.eeEuroapteek e-apteegist saate osta kosmeetikatooteid, toidulisandeid ja käsimüügiravimeid. Lisaks saate e-apteegist oste sooritada igal pool, Teile sobival ajal.
Name
OÜ PharmaSixteen
Registry code
14933899
VAT number
EE102240027
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
10.03.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
2 021 687 €
-87 655 €
-4%
3 316 €
(estimate is approximate)
-505 977 €
3
Submitted
No tax arrears
17%
-25%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Liudmila Kapustina 30.09.1963 (61) | - | Board member | Direct ownership | |
| Osaühing EUROAPTEEK 11036389 | - | - | - | Founder |
| 2020 10.06.2021 | 2021 20.06.2022 | 2022 15.06.2023 | 2023 17.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 1 432 061 € | 2 010 285 € | 2 077 147 € | 2 021 687 € |
| Net profit (loss) for the period | -221 992 € | -622 € | -198 208 € | -87 655 € |
| Profit Margin | -16% | -0% | -10% | -4% |
| Current Assets | 365 912 € | 370 112 € | 391 088 € | 351 538 € |
| Fixed Assets | 659 968 € | 587 696 € | 515 428 € | 19 € |
| Total Assets | 1 025 880 € | 957 808 € | 906 516 € | 351 557 € |
| Current Liabilities | 1 245 372 € | 1 177 922 € | 1 324 838 € | 857 534 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | -219 492 € | -220 114 € | -418 322 € | -505 977 € |
| Employees | 2 | 1 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 552 376.29 € | 9 086.42 € | 13 056.53 € | 5 |
| 2023 Q4 | 511 353.29 € | 9 993.18 € | 14 241.1 € | 5 |
| 2023 Q3 | 389 741.61 € | 10 633.91 € | 17 362.91 € | 5 |
| 2023 Q2 | 548 121.98 € | 19 220.21 € | 18 998.54 € | 4 |
| 2023 Q1 | 580 302.86 € | 11 476.66 € | 18 089.72 € | 5 |
| 2022 Q4 | 524 881.23 € | 8 738.72 € | 17 726.06 € | 4 |
| 2022 Q3 | 479 226.11 € | 13 598.88 € | 21 924.07 € | 4 |
| 2022 Q2 | 542 402.69 € | - | 8 122.06 € | 4 |
| 2022 Q1 | 520 074.32 € | - | 4 010.55 € | 2 |
| 2021 Q4 | 562 514.64 € | 4 320.39 € | 4 220.78 € | 1 |
| 2021 Q3 | 469 494.61 € | - | 5 268.24 € | 1 |
| 2021 Q2 | 482 734.09 € | 4 363.68 € | 4 730.93 € | 1 |
| 2021 Q1 | 471 125.32 € | 3 927.49 € | 4 258.05 € | 1 |
| 2020 Q4 | 515 028.65 € | 9 427.49 € | 9 491.05 € | 1 |
| 2020 Q3 | 442 477.71 € | 11 286.11 € | 12 045.36 € | - |
| 2020 Q2 | 277 025.98 € | - | - | - |
| 2020 Q1 | - | - | - | - |
